The identification of FIH as a key regulator of immune homeostasis and a tumor suppressor under physiological conditions in vivo provides vital information which will guide the future development and application of FIH modulators to treat various inflammatory conditions such as infection, autoimmune disorders, and cancer. This evidence concerns the gene CASR and neoplasm.